Clinical pharmacogenetics of angiotensin II receptor blockers-Reference-Cited by-同舟云学术

Clinical pharmacogenetics of angiotensin II receptor blockers

Published:2020-12-28 Issue:1 Volume: Page:19-25
ISSN:2588-0527
Container-title:Pharmacogenetics and Pharmacogenomics
language:
Short-container-title:Fgen_Fgenom

Author:

Sinitsina I. I.¹^ORCID,Boyarko A. V.²^ORCID,Temirbulatov I. I.¹^ORCID

Affiliation:

1. Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia

2. LLC LMS Clinic

Abstract

This scientific review presents a current data on the effect of genetic polymorphism of CYP2C9 genes and genes encoding components of the renin-angiotensin-aldosterone system (RAAS) on the angiotensin II receptor blockers (ARBs) pharmacokinetics and pharmacodynamics. The data shows that genetic polymorphisms of these genes determine the large interindividual variability of the pharmacological response to ARBs. In this article, we carried out a comprehensive review of recent findings on interpatient variability in antihypertensive therapy response due to genetic factors and individualized treatment approach in ARBs therapy.

Publisher

Publishing House OKI

Subject

General Medicine

Reference47 articles.

1. Ponikowski P, Voors AA, Anker SD, et al 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2016;37:2129-2200m. 10.1093/eurheartj/ehw128

2. Williams B, Mancia G, Spiering W, et al 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104. https://doi.org/10.1093/eurheartj/ehy339

3. Rodgers JE, Patterson JH (2001) Angiotensin II-receptor blockers: Clinical relevance and therapeutic role. Am. J. Heal. Pharm. 2001;58:671–683

4. Сычев Д.А., Раменская Г.В., Игнатьев И.В., Кукес В.Г. Клиническая фармакогенетика: Учебное пособие / Под ред. В.Г. Кукеса, Н.П. Бочкова.- М.:ГЭОТАР Медиа. 2007. [Sychev D.A., Ramenskaya G.V., Ignat'ev I.V., Kukes V.G. Klinicheskaya farmakogenetika: Uchebnoe posobie / Ed by V.G. Kukes, N.P. Bochkova.- M.:GEOTAR Media. 2007 (In Russ).]

5. Isvoran A, Louet M, Vladoiu DL, et al. Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism. Drug Discov Today. 2017;22:366–376. https://doi.org/10.1016/j.drudis.2016.09.015